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ABSTRACT 26 
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) may cause detrimental effects on 27 
physiological function and reproduction of Arctic animals. However, there is a paucity of 28 
information on the link between PFASs and oxidative stress, which can have potential 29 
detrimental effects on key fitness traits, such as cellular homeostasis or reproduction. We 30 
have examined the correlations between multiple blood-based markers of oxidative status 31 
and several perfluoroalkyl carboxylic acids (i.e., with 8 or more carbons) in male Arctic 32 
black-legged kittiwakes (Rissa tridactyla) during the pre-laying period. Higher protein 33 
oxidative damage was found in those birds having higher concentrations of 34 
perfluorododecanoic acid (PFDoA), perfluorotridecanoic acid (PFTriA) and 35 
perfluorotetradecanoic acid (PFTeA). Lower plasmatic non-enzymatic micro-molecular 36 
antioxidants was found in those birds having higher concentrations of 37 
perfluoroundecanoic acid (PFUnA), PFDoA and PFTeA. Effect size estimates showed 38 
that the significant correlations between PFASs and oxidative status markers were 39 
intermediate to strong. The non-enzymatic antioxidant capacity (including antioxidants 40 
of protein origin) was significantly lower in those birds having higher plasma 41 
concentration of linear perfluorooctanesulfonic acid (PFOSlin) only. In contrast, the 42 
activity of the antioxidant enzyme glutathione peroxidase in erythrocytes was not 43 
associated with any PFAS compounds. Our results suggest that increased oxidative stress 44 
might be one consequence of long-chain PFAS contamination. Given the correlative 45 
nature of our study, experimental work will be needed to demonstrate whether PFASs 46 
cause toxic effects on free-living vertebrates through increased oxidative stress.  47 
48 
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INTRODUCTION 49 
Ecotoxicological studies have so far extensively directed their attention toward legacy 50 
persistent organic pollutants (POPs) like organochlorine pesticides (OCPs) and 51 
polychlorobiphenyls (PCBs).1 In contrast, less attention has been given to the 52 
environmental toxicity of other organic contaminants in the Arctic, such as chlorinated 53 
paraffins, phthalates, siloxanes or the perfluoroalkyl and polyfluoroalkyl substances 54 
(PFASs).2 Among these, PFASs remain comparatively much less investigated.3 PFASs 55 
are synthetically manufactured chemicals, produced since the 1950s, that are widely used 56 
for numerous industrial and commercial purposes as water repellents and surfactants (e.g., 57 
impregnation agents for carpets, papers and textiles, fire-fighting foam, non-stick coating 58 
and waterproof clothing).4-5 Chemically and thermally stable, PFASs are highly persistent 59 
in the environment and have been detected globally in both wildlife and humans.6-8 60 
Because of oceanic currents and atmospheric long-range transport, PFASs and their 61 
precursors and breakdown products can reach high latitudes, such as the Arctic Ocean.9-62 
11 Once deposited in the Arctic marine ecosystem, PFASs bio-accumulate in living 63 
organisms and bio-magnify along the food webs.12-16 Importantly, (i) PFASs have long 64 
half-lives, which facilitates their bio-accumulation through the food webs depending on 65 
the species and PFAS congener8; (ii) the long and odd carbon-chain-length PFASs appear 66 
to be more bio-accumulative and toxic than the short and even-chain length PFASs in 67 
wildlife.17-20 68 
It is worthwhile to note that while PFASs have been produced for over 50 years, 69 
it is only since late 1990s that their occurrence in the environment has come under 70 
scientific scrutiny. PFASs have raised recent concerns about their potential physiological 71 
disrupting properties and negative impacts on reproductive fitness in wildlife (multiple 72 
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species in 21; lesser black-backed gull in 22; northern fulmar in 23; zebrafish in 24; tree 73 
swallow in 25; black-legged kittiwake and northern fulmar in 26; black-legged kittiwake 74 
in 27-28; black-legged kittiwake in 29-30; glaucous gull in 31; common eider, black guillemot, 75 
black-legged kittiwake, glaucous gull, arctic skua and great skua in 32).  76 
Increased molecular oxidative damage and disruption of antioxidant defences are 77 
suspected as important mechanisms through which PFASs could be detrimental for cell 78 
function and, possibly, for organism health. Experimental evidence on laboratory models 79 
found that PFASs may increase production of reactive oxygen species (ROS), increase 80 
molecular oxidative damage and up- or down-regulate antioxidant defences.24,33-34 81 
Further work found that the perfluoroundecanoic and perfluorododecanoic acids (PFUnA 82 
and PFDoA, respectively) are equally potent inducers of stress response genes relative to 83 
perfluorooctane sulfonic acid (PFOS) and perfluorononanoic acid (PFNA) and that the 84 
effect of carbon-chain-length was more important than the functional group in 85 
determining oxidative stress.35 There is thus good reason to expect that long-chain PFASs 86 
might cause dysregulation of the oxidative homeostasis, leading to accumulation of 87 
oxidative damage to key biomolecules like proteins or nucleic acids. However, the effect 88 
of PFAS exposure on oxidative stress is almost unknown for wildlife. To the best of our 89 
knowledge, only two studies have addressed this topic in free-living animals. 36 did not 90 
find any significant relationship between plasma PFAS concentrations and the activity of 91 
the antioxidant enzyme superoxide dismutase in plasma of white-tailed eagle nestlings, 92 
while 32 did not find any significant relationship between PFASs and amount of DNA 93 
damage in lymphocytes.  94 
Long-lived species, like many polar seabirds that occupy high trophic levels, are 95 
exposed to a greater risk of accumulation and sensitivity to high concentrations of 96 
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contaminants. In Svalbard (European Arctic), a number of studies showed that black-97 
legged kittiwakes (Rissa tridactyla, hereafter “kittiwake”) are chronically exposed to a 98 
complex cocktail of organic contaminants and trace elements, which are known to 99 
correlate with physiological metrics, impaired individual fitness and population 100 
dynamics.27-30,37-39 It is, however, unknown whether exposure of kittiwakes to PFASs is 101 
associated with markers of oxidative damage and antioxidant protection.  102 
In this study, we have examined the correlations between blood-based markers of 103 
oxidative status and several PFAS compounds in male kittiwakes during the pre-laying 104 
period, while controlling for a number of potential confounding factors that might affect 105 
the oxidative status independently from PFASs (i.e., body condition, body size, both time 106 
and day of blood sampling, hormonal status; reviewed in 40). As with the hormonal status, 107 
we measured plasma levels of testosterone, baseline corticosterone and luteinizing 108 
hormone because prior work found large individual variation among kittiwakes27-28,38 and 109 
significant effects on organism’s oxidative status40, which could affect the relationships 110 
between PFAS and oxidative status markers. We focused on males because this 111 
investigation on oxidative stress is part of a larger project aiming at assessing the overall 112 
consequences (ornament coloration, fecundity, oxidative stress, sexual hormones) of 113 
PFASs exposure in males during the pre-laying stage (nest site defence, pair-bonding, 114 
copulation, nest building) a period during which males appear to be sensitive to 115 
pollutants.38 116 
We have also examined whether the effect size of the association between each 117 
oxidative status marker and each PFAS compound varies according to their carbon-chain-118 
length (C8-14) because the toxicity of PFASs may increase with carbon-chain-length. 119 
 120 
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MATERIALS AND METHODS 121 
Sampling 122 
Fieldwork was conducted in 2016 on a colony of Arctic kittiwakes at Kongsfjord (78° 54' 123 
N; 12° 13' E), Svalbard. Blood samples were collected from 50 adult males during the 124 
pre-laying period (courtship and mating period), from 25th May to 6th June. Birds were 125 
caught on their nest with a loop at the end of a long pole. Within 3 minutes since capture 126 
0.5 ml of blood were taken from the brachial vein using a heparinized syringe and a 25-127 
gauge needle. This blood sample was used to measure oxidative status markers and 128 
hormones. Straightaway, a second sample of venous blood (ca. 2 ml) was collected using 129 
another syringe and this blood sample was used to assess the PFASs burden. Then, tarsus, 130 
skull (head + bill) and wing length were measured using a calliper (nearest 0.1 mm) and 131 
body mass was taken using a Pesola spring balance (nearest 5 grams). Blood samples 132 
were stored on ice in the field. On average, blood samples were stored on ice for 3h40min 133 
38s (min: 1h30; max 9h55) before being centrifuged and stored at -80°C. Plasma and red 134 
blood cells, obtained after centrifugation, were kept frozen separately, either at -80°C for 135 
subsequent oxidative status markers or at -20°C for PFAS analyses. All samples were 136 
analysed within 4 months since collection.  137 
 138 
Hormone assays 139 
Plasma levels of testosterone, baseline corticosterone and luteinizing hormone (LH) were 140 
measured by radioimmunoassay at the Centre d’Etudes Biologiques de Chizé following 141 
protocols previously validated. Briefly, testosterone and corticosterone were extracted 142 
using diethyl ether and ethyl ether, respectively. Plasma concentrations of all three 143 
hormones were measured by radioimmunoassay. As with corticosterone, a commercial 144 
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antiserum against corticosterone-3-(O-carboxy- methyl) oxime bovine serum albumin 145 
conjugate (Biogenesis, UK) was used. The lowest detectable quantities significantly 146 
different from zero at a 90% confidence level were 0.05 ng/ml for testosterone, 0.4 ng/ml 147 
for corticosterone and 1.7 ng/ml for LH. All samples were analysed in duplicate. 148 
Corticosterone and LH were analysed in a single run and the mean coefficient of variation 149 
was 4.9 and 12.0%, respectively. Testosterone was analysed in two runs and the 150 
coefficients of variation were 11.2 and 11.5%. 151 
 152 
Oxidative status markers   153 
One marker of plasma oxidative damage, one marker of plasma non-enzymatic 154 
antioxidant capacity and one red blood cell antioxidant enzyme were measured at the 155 
Centre d’Etudes Biologiques de Chizé using standard methods. Protein carbonyls (marker 156 
of oxidative protein damage) were measured using the Protein Carbonyl Colorimetric 157 
assay (Cayman Chemical Company, Ann Arbor, USA). This assay is based on the 158 
colorimetric method proposed by 41. A same volume of plasma was used for all samples 159 
and the amount of carbonyls was standardised by the plasma protein concentration 160 
according to manufacturer’s instructions. Protein carbonyls were derivatized to 2,4-161 
dinitrophenylhydrazone by reaction with 2,4-dinitrophenylhydrazine (DNPH). The 162 
absorbance was read at 370 nm. The extinction coefficient for DNPH (0.022/µM/cm) was 163 
used to calculate the concentration of protein carbonyls, which was expressed as nmol/mg 164 
protein (amount of carbonyls generated per unit of protein) or as total nmol obtained by 165 
multiplying the concentration of carbonyls by the concentration of plasma proteins (i.e., 166 
total amount of carbonyls in the sample, which is also dependent on the amount of 167 
substrates available, i.e., proteins). The mean coefficient of variation of duplicates was 168 
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11.5%. The metric expressed as nmol/mg indicates the amount of carbonyls that occurs 169 
in a same amount of protein, thus this is standardised by the amount of substrates (i.e., 170 
proteins) that can be carbonylated. The second metric expressed as total amount of 171 
carbonyls indicates the total amount of carbonyls that occurs in the tissue, which is 172 
influenced by the amount of proteins available. This second metric is also important 173 
because accumulation of carbonyls is detrimental for the cells50. The OXY-Adsorbent test 174 
(Diacron International, Italy) was used to quantify the non-enzymatic antioxidant 175 
capacity of plasma against HOCl. Values were expressed as either mM of HOCl 176 
neutralised or as mM of HOCl neutralised/mg protein to estimate the antioxidant potential 177 
of micromolecular antioxidants (e.g., vitamins, carotenoids, glutathione) without the 178 
contribution of proteins (i.e., non-enzymatic micro-molecular antioxidant capacity). The 179 
correlation between OXY values and protein concentration was actually high and 180 
significant (r = 0.76, p < 0.001), which is to be expected because plasma proteins, such 181 
as albumin, are prone to react with HOCl. Although free-radical trapping properties vary 182 
among proteins, standardising OXY values by the concentration of total plasma proteins 183 
gave us some kind of control about the contribution of proteins to OXY. The mean 184 
coefficient of variation of duplicates was 9.4%. The Ransel assay (RANDOX 185 
Laboratories, UK) was used to measure the activity of the antioxidant enzyme glutathione 186 
peroxidase (GPX) in haemolysates (red blood cells diluted with distilled water). Values 187 
were expressed as Units of GPX/mg of protein of haemolysate. The mean coefficient of 188 
variation of duplicates was 8.1%. The Bradford protein assay (Bio-Rad Laboratories, 189 
Hercules, USA) with bovine albumin as a reference standard was used to measure the 190 
concentration of proteins in both plasma samples and haemolysates.  191 
 192 
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PFAS analyses 193 
Perfluoroalkyl carboxylic acids (i.e., PFASs with 8 or more carbons) were analysed in 194 
plasma at the Norwegian Institute for Air Research (NILU) in Tromsø, Norway. The 195 
following compounds were analysed in each plasma sample: perfluorooctanesulfonamide 196 
(PFOSA), perfluorobutanesulfonic acid (PFBS), perfluoropropanesulfonic acid (PFPS), 197 
perfluorohexanesulfonic acid (PFHxS), perfluoroheptanesulfonic acid (PFHpS), 198 
perfluorooctane sulfonic acid (PFOSlin), branched perfluorooctane sulfonic acid 199 
(PFOSbr), perfluorononane sulfonic acid (PFNS), perfluorodecane sulfonic acid 200 
(PFDcS), perfluorohexanoic acid (PFHxA), perfluoroheptanoic acid (PFHpA), 201 
perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoate 202 
(PFDcA), perfluoroundecanoic acid (PFUnA), perfluorododecanoic acid (PFDoA), 203 
perfluorotridecanoic acid (PFTriA), perfluorotetradecanoic acid (PFTeA) and two 204 
precursor compounds, the fluorotelomer sulfonates (6:2 FTS and 8:2 FTS). PFASs with 205 
concentrations below the limit of quantification (LOQ) were replaced with a value equal 206 
to (LOQ × detection frequency) when the detection frequency (percentage of detection) 207 
was > 50%. A 0.2 ml aliquot of plasma spiked with internal standards (carbon labeled 208 
PFAS)42 was extracted in methanol (1 ml) by repeated sonication and vortexing. The 209 
supernatant was cleaned-up using ENVICarb graphitized carbon absorbent and glacial 210 
acetic acid. Extracts were analysed by UPLC/MS/MS. Recovery of the internal standards 211 
ranged between 86.3% and 120%.  Results were validated with blanks (clean and empty 212 
glass tubes treated like a sample) and standard reference material (1957 human serum 213 
from NIST) run with every 10 samples. The deviation of the target concentrations in the 214 
SRMs were within the laboratory's accepted range (69 - 119%). Blanks varied between 215 
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concentrations below the instrument detection limits and 30 pg/g and were applied as the 216 
LOD in the form of 3 times the average concentration. 217 
 218 
Body size and body condition 219 
A body size index was estimated using the PC1 from a PCA of tarsus, skull and wing 220 
length (loadings, 0.73, 0.83 and 0.45, respectively). As far as the body condition, we did 221 
not use the ratio of body mass onto body size nor the residuals of a linear regression of 222 
body mass onto body size because both indices have been criticized.43 Rather we included 223 
both body mass and body size index as factors in the models. In doing so, the coefficient 224 
estimate of body mass is calculated considering the effect of body size, thus the outcome 225 
reflects the effect of body condition on the given marker of oxidative status.43 226 
 227 
Statistical analyses 228 
Generalized linear models were performed using the software STATISTICA 10 229 
(StatSoft. Inc., Tulsa, OK, USA) to assess relationships between each oxidative status 230 
marker (protein carbonylation, non-enzymatic antioxidant capacity, non-enzymatic 231 
micro-molecular antioxidant capacity and glutathione peroxidase) and the following 232 
predictor variables: PFASs congener (PFOSlin, PFNA, PFDcA, PFUnA, PFDoA, PFTriA 233 
or PFTeA), body size index, body mass, hormonal status, day of blood sampling and time 234 
of blood sampling. All predictor variables were scaled to mean of 0 and standard deviation 235 
of 1. These predictor variables were included in all models because prior work showed 236 
that each of them can be significantly associated with oxidative status markers (reviewed 237 
in 40). The two metrics of protein oxidative damage (protein carbonyls per mg of protein 238 
and total protein carbonyls) were combined using the PC1 from a Principal Components 239 
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Analysis (PCA) because they were highly correlated (r = 0.79, p < 0.001).  The hormonal 240 
status was estimated using the PC1 from a PCA of corticosterone, testosterone and 241 
luteinizing hormone (loadings, 0.39, 0.61 and 0.84, respectively). A normal error function 242 
and an identity-link function were applied to models of non-enzymatic antioxidant 243 
capacity and GPX. A gamma error function and an identity-link function were applied to 244 
models of protein carbonyls and non-enzymatic micro-molecular antioxidant capacity. 245 
These functions were selected because the model had the best fitting to the dataset 246 
according to the Akaike Information Criterion. Preliminary analyses showed that the time 247 
elapsed from the collection of blood to its storage was not significantly correlated (p-248 
value > 0.45) with any marker of oxidative status nor hormones, thus it was not further 249 
considered in the analyses. Visual inspection of residuals, Q-Q plots and Cook’s distance 250 
did not highlight any violation of normality and homogeneity of variance nor the presence 251 
of outliers (all samples were below a 0.5 Cook’s distance). The variance inflation factor 252 
was always below 2, indicating that multicollinearity was low. The multicollinearity is 253 
thought to be high and problematic when the variance inflation factor is higher than 5.  254 
The “compute.es package”44 in R45 was used to calculate the standardized effect 255 
size Hedges’ g from test statistics of oxidative status markers that had significant 256 
associations with PFASs (i.e., protein oxidative damage and non-enzymatic micro-257 
molecular antioxidant capacity). The “forestplots function” of the “metafor package” in 258 
R was used to visualise boxplots of effect size and 95% confidence interval. Effect sizes 259 
were considered to be small (Hedges’ g = 0.2, explaining 1% of the variance), 260 
intermediate (g = 0.5, explaining 9% of the variance) or large (g = 0.8, explaining 25% 261 
of the variance) according to46.  262 
 263 
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RESULTS 264 
Concentrations of detectable PFASs are reported in Table 1 together with other variables 265 
measured in kittiwakes. Six out of 20 PFASs (i.e. PFOSlin, PFNA, PFDcA, PFUnA, 266 
PFDoA, PFTriA) were detectable in all individuals, while one PFAS (i.e. PFTeA) was 267 
detectable in 33 out of 50 individuals. PFOSlin, PFUnA and PFTriA concentrations were 268 
the highest of all PFASs measured in the investigated samples, with a percentage 269 
contribution for each kittiwake ranging from 23.4 to 54.5%, from 20.3 to 34.8% and from 270 
11.8 to 35.2%, respectively. The percentage contribution of all other detected PFASs 271 
ranged between 0.1 and 10.6%. PFOSA, PFBS, PFPS, PFHxS, PFHpS, PFOSbr, PFNS, 272 
PFDcS, PFHxA, PFHpA, PFOA, and the two precursor fluorotelomer sulfonates (6:2 FTS 273 
and 8:2 FTS) were below the detection limit in all the investigated samples. 274 
 Protein oxidative damage was significantly higher in those birds having higher 275 
plasma concentration of PFDoA, PFTriA or PFTeA (Table 2). Effect size estimates 276 
increased with chain length of PFASs (indicating an increase of protein damage with 277 
chain length) and were significantly different from zero ) for PFDoA (95% confidence 278 
interval: 0.06 to 1.25), PFTriA (95% confidence interval: 0.01 to 1.20) and PFTeA (95% 279 
confidence interval: 0.29 to 1.54;Fig. 1). The non-enzymatic micro-molecular antioxidant 280 
capacity was significantly lower in those birds having higher plasma concentration of 281 
PFUnA, PFDoA or PFTeA (Table 2). There was also a near-significance tendency of the 282 
non-enzymatic micro-molecular antioxidant capacity to be lower in birds with higher 283 
plasma PFTriA (Table 2). Effect size estimates were larger for longer PFASs (indicating 284 
a decrease of micro-molecular antioxidants with chain length) and were significantly 285 
different from zero for PFUnA (95% confidence interval: -1.20 to -0.02), PFDoA (95% 286 
confidence interval: -1.35 to -0.14) and PFTeA (95% confidence interval: -1.23 to -0.04; 287 
13 
 
Fig. 2). The non-enzymatic antioxidant capacity including the contribution of antioxidant 288 
of protein origin was significantly lower in those birds having higher plasma 289 
concentration of PFOSlin, but it was not associated with any other PFAS congener (Table 290 
2). The activity of GPX was not associated with any PFAS compounds (Table 2). 291 
 Finally, our models showed that (i) kittiwakes in poorer body condition had more 292 
plasma protein carbonyls, (ii) the non-enzymatic antioxidant capacity was higher in 293 
kittiwakes sampled later in the day, and (iii) the non-enzymatic micro-molecular 294 
antioxidant capacity was higher in kittiwakes having lower concentrations of hormones. 295 
 296 
DISCUSSION 297 
Our results provide the first evidence in wild vertebrates that the correlation between 298 
oxidative status markers and PFASs is stronger for long-chain congeners. We found that 299 
male kittiwakes having higher plasma concentrations of long-chain PFASs had more 300 
protein oxidative damage and less plasma antioxidants after controlling statistically for 301 
potentially confounding variables. The non-enzymatic antioxidant capacity (including 302 
antioxidants of protein origin) was significantly lower in kittiwakes having higher plasma 303 
concentration of PFOSlin. On the other hand, the activity of glutathione peroxidase in 304 
erythrocytes was not related to any PFAS congener. Effect size estimates were 305 
intermediate to large, indicating that PFASs explained from 9 to more than 25% of the 306 
variance in protein oxidative damage and non-enzymatic micro-molecular antioxidant 307 
capacity of plasma.46 Intermediate effect sizes are suggested to be biologically 308 
meaningful because average proportions of variance explained in ecological, evolutionary 309 
and physiological studies is usually below 7%.47 Our effect size estimates were also larger 310 
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than those found in the comparison of oxidative status markers between animals living in 311 
polluted (e.g., air pollution, heavy metals) and unpolluted sites.48 312 
PFOSlin, PFUnA and PFTrA concentrations were the highest of all PFASs 313 
measured in the investigated samples, with a percentage contribution for each kittiwake 314 
ranging from 11.8 to 54.5%. The concentration of PFOSlin was higher than that 315 
previously recorded in males from the same kittiwake population in 2012 (13.4 vs. 10.6 316 
pg/g ww in29). In contrast, the average concentrations of PFUnA (10.3 vs. 12.1 pg/g ww 317 
in29) and of PFTrA (8.6 vs. 11.6 pg/g ww in29) were both lower in our study than in prior 318 
work.29 One reason for such differences might be because 29 measured PFASs of male 319 
kittiwakes caught during the chick rearing phase. Work on male glaucous gulls during the 320 
incubation period in Svalbard found levels of PFOSlin similar to ours, while those of 321 
PFUnA (4.4 pg/g ww) and of PFTrA (3.9 pg/g ww) were much lower than those we 322 
recorded.31 323 
The strength of the correlation between oxidative status markers and PFASs 324 
increased with the chain length of the congener. While persistent in the environment, 325 
PFASs with fewer than eight carbons, such as PFHxA, and PFSAs with fewer than six 326 
carbons, such as PFBS, are generally less toxic and bioaccumulative in wildlife and 327 
humans, while exposure of laboratory animals to long-chain congeners produces 328 
detrimental reproductive, developmental, and systemic effects.4,6,18,49 For example, the 329 
toxic effects of PFASs on rat brain cells decreased with increasing carbon chain length.17 330 
Interestingly, the toxic effects of PFASs were attenuated by the antioxidant vitamin E, 331 
indicating a possible involvement of oxidative stress in the reduction of cell viability.49 332 
Further work showed that, compared to short-chain PFASs, long-chain PFASs are 333 
stronger inducers of the response of genes regulating the cell oxidative status.35 334 
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Effects of PFAS exposure on oxidative status have been moderately investigated 335 
in laboratory models and almost unexplored in wild animals. Thus, limited information 336 
is available for a comparison with our results and interpretation. Protein carbonylation 337 
arises from overproduction of ROS by metabolic reactions that use oxygen and shift the 338 
balance between oxidant/antioxidant statuses in favour of the oxidants.50 Protein 339 
carbonylation also occurs when carbonyls are introduced into proteins through the 340 
reactions with lipid oxidative damage products (malondialdehyde and hydroxynonenal).50 341 
Carbonylation is mostly irreversible and results in alteration of protein structure and 342 
function. Only a small fraction of carbonylated proteins can be removed through 343 
proteasome-dependent proteolysis. Work carried out on laboratory models found 344 
evidence that exposure to PFASs may change expression of genes regulating proteasome 345 
activation and proteolysis.6,51-52 It is, however, unclear, whether such changes in gene 346 
expression make proteins one important target of the pro-oxidant effects of PFASs. This 347 
is important because when protein carbonyls accumulate, they tend to aggregate leading 348 
to cell death, tissue injury and development of disorders. Several studies found higher 349 
amounts of plasma protein carbonyls in individuals affected by a given disease,53-54 350 
suggesting a potential role of protein carbonylation in disease progression.  351 
Depletion of circulating non-enzymatic antioxidants might reflect increased 352 
oxidation due to reaction with ROS, reduced intake from diet or mobilisation of 353 
antioxidants from blood to other target tissues. Irrespective of the reason, prior work on 354 
other bird species found evidence that circulating antioxidants may be linked to important 355 
individual or population fitness-related traits. For example, 55 found that barn swallows 356 
(Hirundo rustica) with lower plasma non-enzymatic antioxidants had reduced probability 357 
of survival. 56 found that Gentoo (Pygoscelis papua) and Adélie (Pygoscelis adeliae) 358 
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penguins from increasing populations had higher plasma non-enzymatic antioxidant 359 
capacity than those from decreasing populations.  360 
Metabolic activity is one important source of ROS production. Thus the 361 
association we found between PFASs and oxidative status markers might mirror an effect 362 
of PFASs on metabolism. Prior work on the same kittiwake population found a positive 363 
association between the long-chain PFTriA and resting metabolic rate in females but not 364 
in males.30 Thus, the association between PFASs and oxidative status markers does not 365 
appear, at least for males, to be due to a dysregulation of general body metabolism. The 366 
lack of an effect on metabolic rate does not reject the hypothesis that ROS production 367 
might have been higher in the more contaminated birds. For example, PFASs might have 368 
localised effects on important ROS generators (e.g., mitochondria of red blood cells or of 369 
other target tissues) without compromising the metabolism of the whole organism. In 370 
vitro studies found that PFAS exposure may impair mitochondrial activity and lead to 371 
increased rates of ROS production.57 372 
It is unclear why the activity of glutathione peroxidase was not associated with 373 
any PFAS compound. It might be that up-regulation of this enzyme might have been too 374 
costly for the birds given the imminent start of breeding activity or that any effects of 375 
PFASs on oxidative status did not come through the pathways involving glutathione 376 
peroxidase. The biochemical function of glutathione peroxidase is to reduce hydrogen 377 
peroxide to water and organic hydroperoxides to their corresponding alcohols.50 Thus, we 378 
cannot exclude that results would have been different if another antioxidant enzyme with 379 
a different biochemical function would have been measured. There are, however, many 380 
discrepancies in the literature about the response of antioxidant enzymes to PFAS 381 
exposure. For example, prior work did not find any association between PFASs exposure 382 
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and whole-body catalase activity in the planktonic crustacean Daphnia magna58 or 383 
plasma superoxide dismutase activity in white-tailed eagle (Haliaeetus albicilla) 384 
nestlings.36 In contrast, exposure to PFASs affected catalase activity in hepatocytes of 385 
freshwater tilapia Oreochromis niloticus24 and expression of antioxidant genes Sod1, 386 
Sod2, Gpx2 and Nqo1 in mouse pancreas.59 Irrespective of the mechanisms involved, the 387 
activity of GPX in erythrocytes does not appear to be an informative marker about the 388 
impact on oxidative status of the PFASs we have measured in this work. 389 
 In conclusion, our work shows that higher protein oxidative damage was found in 390 
those birds having higher concentrations of PFDoA, PFTriA and PFTeA. Lower 391 
plasmatic non-enzymatic micro-molecular antioxidants was found in those birds having 392 
higher concentrations of PFUnA, PFDoA and PFTeA. Experimental work will be needed 393 
to ascertain whether the correlation between individual PFAS burden and oxidative status 394 
markers reflects a direct toxic effect of PFASs on oxidative homeostasis. It will also be 395 
important to determine whether increased oxidative damage or decreased antioxidant 396 
defences turn into a reduction in survival probability or lifetime reproductive success. 397 
Resistance against oxidative stress may also decrease with chronological age.60 Thus, we 398 
highlight the importance of assessing in future studies whether the effects of PFASs on 399 
oxidative status markers are stronger in older individuals.   400 
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Table 1. Descriptive statistics of all poly- and perfluorinated alkyl substances congeners, 602 
oxidative status markers (i.e., responde variables) and several individual metrics 603 
(potential confounding factors) measured in 50 male black-legged kittiwakes from 604 
Svalbard. 605 
Variable Mean ± 
Standard 
deviation 
CONTAMINANT  
PFOSlin - Linear perfluorooctane sulfonic acid (ng/g ww) 13.4 ± 6.2 
PFNA - Perfluorononanoic acid (ng/g ww) 2.0 ± 0.9 
PFDcA - Perfluorodecanoic acid (ng/g ww) 2.9 ± 1.2 
PFUnA - Perfluoroundecanoic acid (ng/g ww) 10.3 ± 3.7 
PFDoA - Perfluorododecanoic acid (ng/g ww) 1.7 ± 0.8 
PFTriA - Perfluorotridecanoic acid (ng/g ww) 8.6 ± 3.1 
PFTeA - Perfluorotetradecanoic acid (ng/g ww) 1.0 ± 0.8 
OXIDATIVE STATUS MARKERS – RESPONSE VARIABLES  
Protein carbonyls (nmol/mg protein) 1.8 ± 0.6 
Total protein carbonyls (nmol) 22.5 ± 8.2 
Glutathione peroxidase (Units/mg protein) 0.4 ± 0.2 
Non-enzymatic antioxidant capacity (mM HOCl neutralised) 169.9 ± 37.1 
Non-enzymatic micro-molecular antioxidant capacity (mM HOCl neutralised/mg protein) 13.0 ± 2.0 
INDIVIDUAL TRAITS   
Body mass (g) 416.2 ± 23.1 
Skull length (mm) 93.9 ± 1.6 
Tarsus length (mm) 34.9 ± 1.0 
Wing length (mm) 317.1 ± 6.3 
Baseline corticosterone (ng/ml) 9.6 ± 7.4 
Testosterone (ng/ml) 1.7 ± 1.4 
Luteinizing hormone (ng/ml) 6.2 ± 2.4 
  606 
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Table 2. The table shows the outcomes of generalized linear models performed to test the 607 
effect of each PFASs congener on oxidative status markers. Each model also included a 608 
number of potential confounding factors that may affect oxidative status markers 609 
independently from PFASs. Significant effects are shown in bold type. Note that the 610 
coefficient estimate for the relationship between body mass and the dependent variable 611 
(i.e., oxidative status marker) is calculated considering the effect of body size, thus it 612 
actually indicates the covariation between a given marker and the individual body 613 
condition.43 GPX = glutathione peroxidase; N-E Antioxs = non-enzymatic antioxidant 614 
capacity of plasma; N-E Micromol Antioxs = non-enzymatic micro-molecular 615 
antioxidant capacity of plasma; ce ± se = coefficient estimate ± standard error.  616 
 Protein 
Oxidative 
Damage 
  GPX   N-E 
Antioxs 
  N-E 
Micromol 
Antioxs 
 
            
Main effect 
included in the 
model 
ce ± se P  ce ± se P  ce ± se P  ce ± se p 
            
PFOSlin 0.03±0.12 0.817  0.02±0.02 0.462  -13.7±5.0 0.006  -0.20±0.28 0.484 
sampling date 0.11±0.13 0.406  0.03±0.03 0.309  -16.6±5.0 0.001  0.18±0.31 0.546 
sampling time -0.20±0.11 0.074  0.03±0.02 0.196  14.3±4.6 0.002  0.22±0.28 0.425 
body mass -0.29±0.12 0.013  -0.02±0.03 0.407  4.0±5.0 0.424  0.00±0.29 1.000 
body size -0.02±0.11 0.840  0.02±0.02 0.403  -5.5±4.7 0.236  0.10±0.27 0.704 
hormonal status -0.10±0.11 0.391  0.02±0.02 0.348  4.0±4.7 0.391  -0.94±0.28 0.001 
            
PFNA -0.03±0.13 0.852  0.01±0.03 0.764  -1.0±6.0 0.872  -0.09±0.34 0.804 
sampling date 0.08±0.15 0.580  0.02±0.03 0.433  -10.7±6.0 0.077  0.22±0.35 0.534 
sampling time -0.20±0.11 0.074  0.03±0.02 0.208  14.2±5.0 0.004  0.22±0.28 0.423 
body mass -0.30±0.12 0.011  -0.02±0.03 0.395  5.2±5.4 0.336  0.01±0.29 0.977 
body size -0.01±0.11 0.896  0.02±0.02 0.353  -7.4±5.0 0.137  0.08±0.27 0.768 
hormonal status -0.08±0.11 0.460  0.03±0.02 0.262  0.28±4.9 0.953  -0.98±0.27 <0.001 
            
PFDcA 0.22±0.13 0.106  0.00±0.03 0.904  -0.65±5.8 0.910  -0.49±0.31 0.116 
sampling date 0.22±0.14 0.104  0.02±0.03 0.493  -10.5±5.0 0.075  -0.02±0.33 0.950 
sampling time -0.18±0.11 0.088  0.03±0.02 0.195  14.1±4.9 0.004  0.21±0.27 0.438 
body mass -0.22±0.12 0.056  -0.02±0.03 0.407  5.1±5.6 0.357  -0.07±0.29 0.809 
body size -0.03±0.11 0.795  0.02±0.02 0.352  -7.4±5.0 0.140  0.09±0.27 0.723 
hormonal status -0.14±0.11 0.204  0.03±0.02 0.249  0.24±4.9 0.960  -0.92±0.27 0.001 
            
PFUnA 0.14±0.13 0.268  0.00±0.03 0.970  -3.3±5.6 0.562  -0.62±0.29 0.035 
sampling date 0.19±0.14 0.181  0.02±0.03 0.517  -12.0±5.8 0.038  -0.07±0.32 0.822 
sampling time -0.18±0.11 0.098  0.03±0.02 0.196  13.9±4.9 0.005  0.19±0.27 0.483 
body mass -0.24±0.12 0.045  -0.02±0.03 0.403  4.2±5.7 0.453  -0.13±0.29 0.659 
body size -0.03±0.11 0.807  0.02±0.02 0.348  -7.1±5.0 0.154  0.12±0.26 0.644 
hormonal status -0.13±0.11 0.237  0.03±0.02 0.247  0.86±4.9 0.861  -0.87±0.26 0.001 
            
PFDoA 0.29±0.13 0.024  -0.01±0.03 0.761  -1.5±5.4 0.779  -0.73±0.29 0.012 
sampling date 0.26±0.14 0.066  0.01±0.03 0.625  -10.9±5.6 0.052  -0.10±0.30 0.736 
sampling time -0.18±0.10 0.088  0.03±0.02 0.199  14.1±4.9 0.004  0.21±0.26 0.421 
body mass -0.20±0.11 0.076  -0.02±0.03 0.343  4.9±5.6 0.378  -0.16±0.28 0.563 
body size -0.02±0.11 0.833  0.02±0.02 0.325  -7.2±5.0 0.148  0.14±0.25 0.574 
hormonal status -0.14±0.10 0.176  0.03±0.02 0.220  0.21±4.8 0.965  -0.95±0.25 <0.001 
            
PFTriA 0.30±0.14 0.036  0.00±0.03 0.923  2.0±5.9 0.735  -0.58±0.32 0.064 
sampling date 0.26±0.15 0.075  0.02±0.03 0.597  -8.8±6.1 0.153  -0.12±0.34 0.725 
sampling time -0.18±0.11 0.094  0.03±0.02 0.214  14.5±5.1 0.004  0.10±0.27 0.725 
body mass -0.26±0.11 0.026  -0.02±0.03 0.368  5.7±5.5 0.299  -0.08±0.28 0.763 
body size -0.06±0.12 0.632  0.02±0.02 0.348  -7.9±5.2 0.124  0.20±0.27 0.454 
hormonal status -0.14±0.11 0.181  0.03±0.02 0.226  -0.13±4.9 0.979  -0.92±0.26 <0.001 
            
PFTeA 0.33±0.11 0.003  -0.02±0.03 0.482  7.4±5.4 0.171  -0.65±0.29 0.028 
sampling date 0.22±0.12 0.070  0.01±0.02 0.664  -7.4±5.1 0.145  0.05±0.29 0.852 
sampling time -0.27±0.11 0.013  0.03±0.02 0.149  12.3±5.0 0.015  0.40±0.27 0.144 
body mass -0.25±0.11 0.018  -0.03±0.03 0.317  6.4±5.3 0.227  -0.05±0.28 0.858 
body size -0.05±0.11 0.668  0.03±0.02 0.275  -9.0±5.0 0.072  0.19±0.26 0.461 
hormonal status -0.19±0.10 0.062  0.03±0.02 0.171  -1.9±4.9 0.704  -0.84±0.27 0.001 
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Figure captions 618 
Figure 1. Mean estimates of effect size and 95% confidence interval are shown. These 619 
were calculated from the statistical outcomes showing the effect of each PFAS congener 620 
on protein oxidative damage. Estimates are positive when values of damage are higher in 621 
birds having higher plasma concentration of a given PFAS congener. Note that effect size 622 
estimates are significant when the 95% confidence interval does not include zero. 623 
Numbers in bracket indicate carbon-chain-length of each PFAS congener.  624 
 625 
Figure 2. Mean estimates of effect size and 95% confidence interval were calculated from 626 
the statistical outcomes showing the effect of each PFAS congener on plasma non-627 
enzymatic micromolecular antioxidant capacity. Estimates are negative when values of 628 
antioxidants are lower in birds having higher plasma concentration of a given PFAS 629 
congener. Note that effect size estimates are significant when the 95% confidence interval 630 
does not include zero. Numbers in bracket indicate carbon-chain-length of each PFAS 631 
congener. 632 
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